AmCham Board Priorities: Karin Bacmanakova, Bristol Myers Squibb, and innovative health care

Health care is a basic building block for quality of life.

A good health care system prevents families from being sick, diagnoses them quickly and accurately when they are, treats them effectively to avoid relapse or side effects such as infection, and does all this at a cost that a society can afford without significant burden. The benefits are widespread: families spend more time earning and enjoying life, companies can rely on a workforce that shows up to the office physically and mentally fit, and the government can expect that its citizens will generate much higher economic output and tax revenues.

This presents a challenge and an opportunity. The challenge is maintaining or increasing these benefits as the population ages. More people will require care; a smaller proportion of them will pay for the system by generating economic output and tax revenues.

The opportunity is solving the challenge not just for Czechia, but for the aging transatlantic population. Nations all over the planet are going to engage in a competition to see who can create the most innovative health care system not only to improve the health of their citizens, but also to attract innovative entrepreneurs and scientists to work and live in their country to create technological and procedural innovations that can be exported globally. 

AmCham is glad we have Karin Bacmanakova of Bristol Myers Squibb on our board of directors to oversee how we support the development of an innovative health care system in Czechia.

“The first step is a different mindset,” Karin says. “We have all the talent and resources we need to get to a much higher level.”

Other Posts about AmCham Board:
https://lnkd.in/dFBfqmtm
https://lnkd.in/e5MF8CRt